Allergan Unanimously Rejects Revised Valeant Bid

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 10 (Bloomberg) -- Bloomberg’s Betty Liu reports that Allergan’s board has unanimously rejected an improved offer from Valeant, claiming it undervalues the company. She speaks on Bloomberg Television’s “In The Loop.”

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change